According to ScienceDaily, researchers have developed a copper-based compound that restores the brain's ability to clear toxic Alzheimer's proteins. In laboratory experiments, the drug dramatically reduced amyloid buildup and improved memory. Notably, the compound has already been tested in humans for other neurological conditions, potentially opening a fast-track path to clinical trials for Alzheimer's treatment.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton